Advancing Head and Neck Cancer Survival Prediction via Multi-Label Learning and Deep Model Interpretation
Meixu Chen1, Kai Wang1,2, Jing Wang1
1University of Texas Southwestern Medical Center, Dallas, TX.
Arxiv
|May 20, 2024
Summary
This study introduces an interpretable deep learning framework for Head and Neck Cancer (HNC) survival prediction. The model accurately predicts multiple outcomes and provides visual explanations, aiding personalized radiation therapy (RT) management.
Area of Science:
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Accurate survival prediction is crucial for personalized Head and Neck Cancer (HNC) management following curative Radiation Therapy (RT).
- Existing models often lack interpretability and the ability to predict multiple survival outcomes simultaneously.
- Developing reliable prognostic tools is essential for optimizing patient treatment strategies.
Approach:
- Proposes IMLSP (Interpretable Multi-Label multi-modal deep Survival Prediction), a novel framework for simultaneous prediction of multiple HNC survival outcomes.
- Utilizes Multi-Task Logistic Regression (MTLR) layers to transform survival prediction into a multi-time point classification task.
- Introduces Grad-Team, a Gradient-weighted Time-event activation mapping technique for visual explanation of deep survival predictions.
Key Points:
- IMLSP outperforms single-modal and single-label models on the RADCURE HNC dataset for all survival outcomes.
- Visual explanations (activation maps) reveal the model's focus on tumor and nodal volumes, varying between high- and low-risk patients.
- Multi-label learning enhances prognostic performance and learning efficiency.
Conclusions:
- The interpretable multi-label survival prediction model shows promise for understanding AI decision-making in oncology.
- This approach facilitates personalized treatment planning for Head and Neck Cancer patients undergoing Radiation Therapy.
- The framework offers a pathway toward more transparent and effective AI-driven cancer care.
Related Concept Videos
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Kaplan-Meier Approach
132
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
132


